DOI: 10.1001/jamanetworkopen.2023.29006 ISSN:

Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act

James D. Chambers, Katherine A. Clifford, Daniel E. Enright, Peter J. Neumann
  • General Medicine

This cohort study assesses rates at which orphan drugs approved by the US Food and Drug Administration were also approved for supplemental (follow-on) indications.

More from our Archive